Nobori Stent Shows Less Vascular Inflammation and Early Recovery of Endothelial Function Compared With Cypher Stent  by Pendyala, Lakshmana K. et al.
DJ A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 5 , N O . 4 , 2 0 1 2
© 2 0 1 2 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 1 . 1 1 . 0 1 3Nobori Stent Shows Less Vascular Inflammation
and Early Recovery of Endothelial Function
Compared With Cypher Stent
Lakshmana K. Pendyala, MD,* Daisuke Matsumoto, MD, PHD,*
Toshiro Shinke, MD, PHD,* Taizo Iwasaki, PHD,† Ryota Sugimoto, MENG,†
ongming Hou, MD, PHD,* Jack P. Chen, MD,*‡ Jaipal Singh, PHD,*
Spencer B. King III, MD,*‡ Nicolas Chronos, MD,*‡ Jinsheng Li, MD, PHD*
Atlanta, Georgia; and Kanagawa, Japan
Objectives The current study sought to examine inﬂammation at the stented segments of Nobori
(Terumo Corporation, Tokyo, Japan) and Cypher (Cordis, Miami, Florida) drug-eluting stents (DES), as
well as free radical production and endothelial function of the adjacent nonstented segments in a
pig coronary model.
Background Nobori is a novel DES, incorporating a biolimus A9-eluting biodegradable polymer
coated only on the abluminal surface of the stent. These unique features may favorably affect in-
ﬂammation and endothelial function, as compared to the currently marketed DES. Presently, pre-
clinical data on direct comparison of the various generations of DES are not available.
Methods A total of 18 DES were implanted in pig coronary arteries and subsequently explanted at
1 month. Stented segments were assessed by angiography and histology. Ex vivo vasomotor func-
tion and superoxide production in segments proximal and distal to the stent were determined. The
vasoconstriction, endothelial-dependent relaxation, and endothelial-independent relaxation of proxi-
mal and distal nonstented segments were measured.
Results Histological evaluation revealed lower inﬂammatory response with Nobori than with
Cypher DES. There is trend for lower angiographic percentage diameter stenosis in Nobori versus
Cypher groups (p  0.054). There was increased endothelium-dependent relaxation, decreased en-
dothelin-1–mediated contraction, and less superoxide production in the vessel segments proximal
and distal to Nobori versus Cypher stents.
Conclusions Our data show signiﬁcantly lower inﬂammatory response in the stented segments, and
rapid recovery of endothelial function of peristent segments in the Nobori group compared with
Cypher DES group at 1 month in porcine coronary artery model. (J Am Coll Cardiol Intv 2012;5:
436–44) © 2012 by the American College of Cardiology Foundation
From *Saint Joseph’s Translational Research Institute, Atlanta, Georgia; †Terumo Corporation, Research and Development
Headquarters, Kanagawa, Japan; and the ‡Saint Joseph’s Hospital of Atlanta, Atlanta, Georgia. Dr. Iwasaki and Mr. Sugimoto are
full-time employees of Terumo Corporation. Dr. Hou is a full-time employee of Boston Scientific Corporation. All other authors
have reported that they have no relationships relevant to the contents of this paper to disclose. Robert S. Schwartz, MD, served
as Guest Editor for this paper.Manuscript received April 19, 2011; revised manuscript received September 22, 2011, accepted November 21, 2011.
a
f
p
d
a
a
i
A
d
k
m
a
a
(
i
s
t
w
u
a
b
v
s
a
d
c
l
a
e
i
f
m
2
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 5 , N O . 4 , 2 0 1 2 Pendyala et al.
A P R I L 2 0 1 2 : 4 3 6 – 4 4 Endothelial Dysfunction and Coronary DES
437Development and widespread use of drug-eluting stents
(DES) has provided a novel and efficacious treatment for
coronary artery disease, allowing for localized elution of
neointimal-inhibiting drugs, thereby reducing in-stent re-
stenosis and target lesion revascularization rates compared
with bare-metal stents (BMS) (1,2). However, numerous
reports have suggested increased incidences of late stent
thrombosis and very late stent thrombosis with the first-
generation DES, especially after discontinuation of dual
antiplatelet therapy (3,4). Although many factors, such as
patient, lesion, as well as procedural characteristics are likely
contributory, clinical, histopathologic, and pathophysiological
studies have indicated that delayed arterial healing and poor
re-endothelialization may play a major role in the pathogenesis
of late stent thrombosis (5,6). The possible interaction of the
potent antiproliferative agent and permanent nonbiodegrad-
able synthetic polymer have raised concerns regarding delayed
arterial healing and poor re-endothelialization, persistent in-
flammatory responses that may lead to impaired endothelial
function at and adjacent to the stent site (5–7).
Potential etiologies and molecular mechanisms of this
complex phenomenon (endothelial dysfunction) after DES im-
plantation remain incompletely defined. Multiple factors may be
involved, including direct toxic effect from the entrapped drug
and/or an acute or delayed hypersensitivity reaction from the
polymer and/or drug. Accordingly, we hypothesized that the
endothelium-dependent vasomotor functional responses of coro-
nary artery segments proximal and distal to the stent implantation
site may be affected during and after the period of drug release.
The new polymers and/or drugs with enhanced biocompatibility
may reduce inflammation and its attendant effects.
Thus, the purpose of the present study is to assess the
vasomotor function of the adjacent coronary conduit vessel
segments proximal and distal to the stent implantation site
along with inflammatory response to Nobori (Terumo
Corporation, Tokyo, Japan) and Cypher (Cordis, Miami,
Florida) stents in a pig coronary model.
Methods
A total of 18 DES were implanted into the coronary arteries
of 8 farm pigs and subsequently explanted at 1 month. The
stent/vessel diameter ratio was approximately 15%. All 18
DES (Cypher, n  9 and Nobori, n  9) were blindly
ssessed for histology of the stented segment and vasomotor
unction and superoxide production of vascular segment
roximal and distal to stent. Vasoconstriction, endothelial-
ependent relaxation, and endothelial-independent relax-
tion were measured.
Stent implant protocol. Pigs received 81-mg acetylsalicylic
cid and 75-mg clopidogrel daily for 3 days before stent
mplantation and then daily afterward until the termination.
ll pigs were fasted overnight before stent implant proce-
ure. They were sedated by intramuscular injection ofetamine 20 mg/kg, xylazine 2 mg/kg, and atropine 0.05
g/kg. After intubation, general anesthesia was induced
nd maintained with isoflurane (2.5%). Electrocardiogram
nd blood pressure were continuously monitored. Nobori
Terumo Corporation) and Cypher (Cordis) stents were
dentical in size and length (3.0 to 3.5/23 to 28 mm). With
ystemic heparin (200 U/kg) administration, activated clot-
ing time measurements were performed. Eighteen stents
ere respectively implanted in the pig coronary arteries
sing quantitative coronary angiography, to obtain stent/
rtery ratio 1.15:1. Additional inflations were performed
ased on the target site diameter. Angiographic target-
essel diameter, stent-to-arterial diameter ratio, and post-
tent minimal lumen diameter were measured in all animals
t implantation.
Angiography, termination, and tissue harvest. All pigs un-
erwent repeat angiographic evaluation (with heparin anti-
oagulation) 1 month after implantation to determine the
ate lumen loss and percentage diameter stenosis. After
ngiographic follow-up restudy, pigs were terminated by
xsanguination while still under anesthesia. The heart was
mmediately harvested and placed into 4°C Kreb solution
reshly prepared every day (in
mol/l: NaCl, 120; MgSO4,
1.17; KH2PO4, 1.18; NaHCO3,
5.0; CaCl2, 2.5; KCl, 4.7; glu-
cose, 5.5 in the presence of 10
mol/l indomethacin at pH
7.40). The arterial segments
proximal and distal to the
stented segment were dissected
for vasomotor function and su-
peroxide production. The vascular segment sample that is
immediately adjacent to the stent was used for superoxide
production studies, and farther segments were used for the
vasoreactivity studies (8).
Subsequently, the heart was again immediately placed
into 4°C Kreb solution. The heart was washed to clear the
blood and then photographed. The stented portions of the
vessels were processed and embedded in methyl methacry-
late resin. Each block was trimmed and oriented to obtain
transverse 5-m thick sections of the vessel, using a heavy-
duty tungsten-carbide blade. Sections from proximal, medial,
and distal vessel portions were mounted on glass slides, deplasti-
cized, and stained with hematoxylin-eosin and Verhoeff-Masson
Trichrome (VM) stain (Sigma-Aldrich, St. Louis, Missouri) for
visualization and histopathological evaluation.
Endothelial function proximal and distal to the stented
segments. Hearts were washed in 4°C Kreb solution. The
conduit coronary arterial segments proximal and distal (5
mm) to the stent were carefully dissected and cleaned of
connective tissue. The vessels were cut into 4-mm long
Abbreviations
and Acronyms
BMS  bare-metal stent(s)
DES  drug-eluting stent(s)
IEL  internal elastic lamina
NO  nitric oxide
VM  Verhoeff-Masson
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438chambers (Radnoti Glass Technology Inc., Monrovia,
California).
Vasoconstriction was induced by addition of 40-mmol/l
KCl twice followed by 100-mmol/l KCl to the organ
chamber. Rings were contracted with prostaglandin F2-alpha
until reaching a stable contraction plateau (7 min). The
rings were then exposed to various concentrations of
endothelium-dependent (substance P) and endothelium-
independent (sodium nitroprusside) vasodilators. With
incubation of NG-nitro-L-arginine methyl ester for 30
min, endothelium-dependent relaxation response was
repeated with substance P. At the end of the study, the
rings were contracted by endothelin-1. Between the dose
responses, the rings were washed for 45 min. Isometric
tension was digitized, acquired, and analyzed using a
PowerLab (ADInstruments Inc., Colorado Springs, Col-
orado).
Measurement of superoxide production proximal and distal
to stented segments. Superoxide productions in the conduit
oronary arterial segments proximal and distal to the stent
ere performed using a luminometer (8). Free radical
roduction O2
·) was assessed by the lucigenin chemilumi-
nescence method using a tube luminometer (FB 12, Zylux
Corporation, Maryville, Tennessee).
Histopathology. The histological specimens were excised
rom the proximal, middle, and distal potions of each stent.
istological sections were evaluated at high magnification
sing bright field microscopy. Proximal, middle, and distal
ections of stented arterial segments were scored for inflam-
Cypher 
Proximal Mi
Nobori 
Proximal Mi
Figure 1. Low Magnification Microscopic Images of Cypher and Nobori Ste
The representative low magniﬁcations microscopic images (20) of sections st
with Cypher and Nobori stents.ation. The following specific morphological criteria were
valuated for each section using a semiquantitative rating
cale of 0 none, 1mild, 2moderate, 3 severe, where
represented the lowest response and 3 represented the
ighest response of all tissues analyzed in this study within each
ategory.
Histomorphometry. Morphometric analysis was performed
by computer-assisted planimetry on proximal, middle, and
distal section cuts from each stented vessel. Low-magnification
digital images of VM-stained sections were recorded. The
lumen, internal elastic lamina (IEL), and external elastic
lamina were traced and area measurements obtained; the areas
of the neointima and media were obtained by subtraction
of the lumen from the IEL and IEL from external elastic
lamina, respectively. The neointimal thickness at each
stent strut site was measured as well. The injury score was
measured in 3 stented segments and then averaged in
each vessel using the Schwartz et al. method (9). The
histological percentage area stenosis was calculated ac-
cording to the following formula: [1 – (luminal area/IEL
area)  100].
Statistics. All data were expressed as mean  standard
rror. Statistical analysis was performed by Student t tests
etween the Cypher and Nobori groups. Non-numerical
ata (such as histopathologic scoring) were expressed as
edian with quartile ranges and compared using rank-sum
ests between groups. A p value  0.05 was considered
ignificant between groups.
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439Results
A total of 18 DES stents were implanted in native coronary
arteries. The average body weight of the animals was 51.8
1.8 kg at initial implantation and 62.2  1.6 kg at
ermination.
Angiographic evaluation. Nine Cypher stents were im-
lanted in the left anterior descending (n  3), left
ircumflex (n  3), and right coronary (n  3) arteries,
respectively. Nine Nobori stents were deployed in left
anterior descending (n  3), left circumflex (n  1), and
right coronary (n  5) arteries, respectively. The respective
target vessel diameters (2.99  0.09 and 3.01  0.07; p 
0.85) and the baseline stent/artery ratios (1.13  0.02 and
1.17  0.02; p  0.20) were similar between Cypher and
Nobori groups. At 1 month after implantation, there is a
strong trend for lower mean angiographic percentage ste-
nosis in the Nobori group than in the Cypher group (4.0 
2.6% vs. 25.5  10.0%, respectively; p  0.054).
Histopathology and histomorphometry. Stented and non-
tented coronary segments (proximal and distal to stented
egment), were carefully dissected from perivascular connec-
Inflam
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Figure 2. Histopathologic Scoring for Inflammation in Cypher and Nobori G
(A) The Nobori group showed signiﬁcantly lower inﬂammation. High magniﬁcatio
shown. White arrows indicate the inﬂammatory cells. *Nobori group showed signiﬁcantive and fat tissue. All 9 Nobori stents were easily isolated
rom the surface of the myocardium without any difficulties.
hree of the 9 Cypher coronary segments displayed evi-
ence of inflammation, with diffuse reddish discoloration as
ell as severe fibrosis around the stents.
The representative low-magnification microscopic images of
M-stained sections from coronary segments implanted with
ypher and Nobori stents are shown in Figure 1.
All histopathologic scoring was performed using high
agnification (54 sections). The injury score was 1.02 
.01 in the Nobori group and 1.20  0.10 in the Cypher
roup (p  0.098). The Nobori group showed significantly
ower inflammation (Grade 1: 93% and Grade 2: 7% in
obori vs. Grade 1: 48%; Grade 2: 22%, and Grade 3: 30%
n Cypher; p  0.001) (Fig. 2) than the Cypher group.
All histomorphometric parameters were measured using
ow-magnification VM specimens (54 sections). There were
o significant differences in neointimal area (1.63  0.21
m2 in Nobori vs. 2.85 0.69 mm2 in Cypher; p 0.251),
uminal area (5.72  0.24 mm2 in Nobori vs. 5.03  0.58
mm2 in Cypher; p  0.295), IEL area (7.34  0.22 in
ion
Nobori
 Grade 3
 Grade 2
 Grade 1
 Grade 0
lumen 
strut void 
GC 
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*
200) of (B) Cypher and (C) Nobori hematoxylin-eosin–stained sections aremat
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440Nobori vs. 7.88  0.73 mm2 in Cypher; p  0.493),
external elastic lamina area (8.63  0.26 mm2 in Nobori vs.
.91 1.07 mm2 in Cypher; p  0.263), and medial area
1.29  0.05 mm2 in Nobori vs. 2.03  0.55 mm2 in
Cypher; p  0.860) between groups. Likewise, no signifi-
cant difference in neointimal thickness (0.16  0.03 mm in
obori vs. 0.24  0.06 mm in Cypher; p  0.48) was
bserved between groups.
Vasomotor function proximal and distal to stent. The arte-
rial segments proximal (Cypher, n  9; Nobori, n  8) and
distal (Cypher, n  9; Nobori, n  9) to the stent were cut
into 4-mm long segments. Vasomotor function was studied
using organ chambers.
Contractile response to 5 mol/l prostaglandin F2-alpha/100-
mmol/l KCl was similar between Cypher and Nobori groups
(0.74  0.02% vs. 0.66  0.13%; p  0.74 in proximal and
.77  0.18% vs. 0.95  0.11%; p  0.42 in distal
egments, respectively). The contractile responses to 0.1
mol/l endothelin-1/100-mmol/l KCl were significantly
lower in Nobori than in Cypher proximal segments (0.53 
0.09% vs. 1.02 0.08%; p 0.02) but were not statistically
different in the distal segments (1.25  0.16% vs. 1.92 
0.09%; p  0.07) (Fig. 3).
Vessel segments proximal and distal to Nobori stents
showed concentration-dependent relaxation in response to
substance P. However, the vessel segments proximal and
distal to Cypher stents showed reduced relaxation at higher
concentrations of substance P (Fig. 4). The Nobori group
showed significantly higher relaxation at maximal substance
P concentration than the Cypher group did (80.9  2% vs.
42.7  0.6%, p  0.001 for proximal and 77.9  2% vs.
53.1  1.9%, p  0.001 for distal segments, respectively).
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Figure 3. Contractile Response to ET-1 Proximal and Distal to Stent
Contractile responses to 0.1 mol/l endothelin (ET)-1/100 mmol/l KCl were sig
ment. Dist  distal; Prox  proximal.Endothelium-independent vasodilator, sodium nitro-
prusside, induced concentration-dependent relaxation in
both Nobori and Cypher groups (Fig. 5). There was no
difference between Nobori and Cypher groups at the 4 lower
concentrations of sodium nitroprusside. However, at maximal
sodium nitroprusside concentration, Nobori produced greater
relaxation as compared to Cypher (88.6  0.1% vs. 81.6 
0.1%, p  0.03 in proximal and 90.7  1% vs. 83.5  2%,
p  0.03 in distal segments, respectively).
In the presence of NG-nitro-L-arginine methyl ester, a
nitric oxide (NO) synthase inhibitor, maximal endothelial-
dependent relaxation to substance P was significantly atten-
uated in both the groups (Cypher and Nobori) in proximal
and distal segments (p  0.05) (Fig. 6).
Superoxide production proximal and distal to stent. The
rterial segments proximal (Cypher, n  9; Nobori, n  9)
nd distal (Cypher, n  9; Nobori, n  8) to the stent were
ut into segments 4-mm long. Superoxide production mea-
ured by lucigenin chemiluminescence was significantly
ower in Nobori than in Cypher groups (8.2  0.8 vs. 20.5 
.4 relative light units/s/mg of tissue, p  0.001 in proximal
nd 12.1 1.9 vs. 32.33.4 RLU/s/mg of tissue, p 0.01 in
istal segments, respectively) (Fig. 7).
iscussion
In this in vitro porcine model, we investigated the vascular
inflammation, endothelial function, and free radical produc-
tion at 28 days after DES implantation. Our data demon-
strate that, compared with Cypher stents, the Nobori DES
is associated with increased endothelium-dependent relax-
ation, decreased endothelin-1–mediated contraction, and
0.00
0.40
0.80
1.20
1.60
2.00
2.40
Cypher-Dist Nobori-Dist
Contractile Responses of Distal to Stent
tly lower in the Nobori group than in the Cypher group in the proximal seg-niﬁcan
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441lower superoxide production. Moreover, stented segments
of Nobori also showed a lower inflammatory score. Similar
to our current study findings, several clinical studies have
shown long-term (6 to 9 months) vasomotor dysfunction
involving the coronary segments proximal and/or distal to
both sirolimus- and paclitaxel-eluting stents (10–13). At
the same time, our results are somewhat in contrast to the
results of a recent publication by van den Heuvel et al. (14)
showing that in healthy porcine coronaries, sirolimus-
eluting stents did not affect distal coronary vascular func-
tion, whereas paclitaxel-eluting stents altered distal endo-
thelial function of small arteries under conditions of reduced
NO bioavailability. There are significant differences in both
studies, including the animal model, stent length, implan-
tation technique, and the follow-up duration. To get a
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Figure 4. Relaxation Response to Substance P Proximal and Distal to Sten
The Nobori group showed signiﬁcantly higher relaxation at maximal substance P
Abbreviations as in Figure 3.demonstrated signiﬁcantly greater relaxation to SNP at maximal dose than the Cypher grobust signal and to better understand the underlying
mechanisms, we used much longer stents (28 vs. 13 mm)
compared with those used by van den Heuvel et al. (14) that
might be contributing to the differences in the observed
results.
Delayed healing, hypersensitivity reaction to drug and/or
polymer, insufficient re-endothelialization, or dysfunctional
endothelium have been implicated in the development of
stent thrombosis (5–7). Much of our basic understanding of
the vascular responses (both anatomical and physiological)
to DES has been generated from animal studies. Given the
limited resolution of conventional angiography, intravascu-
lar ultrasound, or other newer imaging modalities, histolog-
ical studies remain the most commonly used method for
evaluating arterial responses to vascular stent implants (6).
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442Although arterial repair after stent placement in normal
animals occur much more rapidly than in humans, the
sequence and time line of biological responses share many
similarities (15). In a swine model after BMS implantation,
endothelial cell coverage is observed in approximately 40%
of animals after 3 days, in about 80% after 7 days, and
almost 100% after 14 days (6). In contrast to BMS,
polymeric DES implantation in an animal model is noted to
provoke progressive granulomatous and eosinophilic reac-
tions starting around 28 days with continued increase up to
6 months (1 month, 14%; 3 months, 43%; and 6 months,
60%) (7). The likely explanation for these findings is a local
hypersensitivity reaction to the nonerodible polymers incor-
porated into first-generation stents (Cypher: polyethylene-
co-vinyl acetate and poly n-butyl methacrylate; Taxus: poly
[styrene-b-isobutylene-b-styrene]). Although the eluted
and retained drug may also contribute to these effects, the
hypersensitivity reaction peaks only after complete release of
drug in the pig model (i.e., 60 days), reinforcing the
polymer as the more likely culprit. Tada et al. (16) recently
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Figure 6. Relaxation Responses to Substance P Proximal and Distal to Ste
In the presence of NG-nitro-L-arginine methyl ester (L-NAME), both the Cypher
and Dist segments. *p  0.05, substance P versus substance P  L-NAME. Othreported granulomas in 10% of pigs at 28 days and 23.1% at180 days after Cypher DES implantation. In contrast,
neither high nor low doses of polymer-free biolimus A9
showed any granulomas during the same periods.
The Nobori stent that is used in this study has a
bioresorbable polymer (polylactic acid) for biolimus A9
elution only on the abluminal surface, which provides a
small initial burst and sustained simultaneous drug release
and polymer degradation taking place over a period of more
than 6 months (12). Interestingly, in our study, 1 Cypher
stent and 1 Nobori stent were implanted in the same pig. At
explantation, we noticed a severe hypersensitivity reaction
with the Cypher stent but not with the Nobori stent. This
observation suggests that the hypersensitivity response may
be specific to the stent but not to the animal. Recently,
Hamilos et al. (13) examined the effects of various
drug-polymer devices on endothelium-dependent coro-
nary vasomotion. Their study comparing the Cypher
stent to the Nobori stent reported almost complete
preservation of endothelium-dependent vasomotion in
adjacent segments for the Nobori stent but not for the
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443generation DES caused endothelial dysfunction in the
implanted coronary vessels, whereas newer generation
DES, such as Nobori, preserved normal endothelium-
dependent vasomotion.
Molecular mechanisms of impairment of vascular endo-
thelial function after DES implantation are not well under-
stood. Multiple factors may be involved, including a direct
toxic effect of the entrapped drug and/or an acute or delayed
hypersensitivity reaction to the polymer. Long et al. (17), in
mice model, reported that acute in vitro sirolimus treat-
ent, as well as genetic deletion of the sirolimus-receptor
soform FKBP12.6, increased protein kinase C-mediated
ndothelial NO synthase threonine 495 phosphorylation,
hereby leading to decreased vascular NO production and
ubsequent endothelial dysfunction. Our studies have
hown that superoxide production was significantly lower
n the Nobori than in the Cypher group. Similar to our
rior reported pre-clinical data with paclitaxel-eluting
tents as well as with Cypher stents, persistent inflam-
ation in the stented region contributes to increased free
adical production. Oxygen free radical production de-
letes NO reserves, ultimately contributing to endothelial
ysfunction (8).
Chronically increased production of reactive oxygen species
eads to decreased NO bioavailability (secondarily to inactiva-
ion by O2
·), resulting in impairment of endothelium-
ediated vascular response. The importance of NO for
ndothelium-dependent relaxation was also confirmed in our
xperiment by significant blockage of vasorelaxation in the
resence of NO synthase inhibited NW-nitro-L-arginine
methyl ester.
Thus, chronic inflammation, as well as potentiation of
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Figure 7. Superoxide Anion Production Proximal and Distal to Stent
Superoxide production measured by lucigenin chemiluminescence was signiﬁc
Nobori versus Cypher in proximal and distal segments. RLU  relative light unsuperoxide production, in the stented segment may contrib-ute to endothelial dysfunction of the peristent segment.
Beyond vasorelaxation dysfunction, our data also illustrated
significantly increased contractile response to endothelin-1
in the Cypher group. The clinical implications and long-
term significance of this endothelial dysfunction related to
DES is currently unknown.
Study limitations. The study was limited to Cypher and
obori DES and did not include BMS or stents coated with
olymer only. Therefore, the potential interactive contribu-
ions of stent platform and polymer cannot be separated
rom the presence of drug. Additionally, our protocol did
ot include a bolus of clopidogrel, a recommended practice
n clinical use. Because the DES were deployed in nondis-
ased porcine arteries, the results may not correspond to
uman atherosclerotic disease.
onclusions
In this study, a novel DES (Nobori) was tested in pig
coronary arteries and compared with Cypher DES. Vaso-
motor function, free radical production of vessel segments
proximal and distal to the stent, and histological measure-
ments of stented segments were performed. There was an
increased endothelium-dependent relaxation, decreased
endothelin-1 contraction, and lower superoxide production
in the vessel segments proximal and distal to the stent, along
with reduced inflammation of the stented segments in the
Nobori group. Our study demonstrated that the Nobori
stent, using a novel polymer and polymer-coating design
elicited significantly lower inflammatory response and rapid
recovery of endothelial function as compared to the Cypher
0.0
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* 
lower in the Nobori group than it was in the Cypher group. *p  0.01,
her abbreviations as in Figure 3.antlyDES.
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